STAQ Pharma
Bringing Safety, Transparency, Availability, and Quality to Outsourced Medications
An ongoing shortage of albuterol, a critical medicine for treating breathing problems, has intensified following the shutdown of a major supplier to U.S. hospitals. STAQ Pharma, a hospital-owned 503B outsourcing supplier, has been instrumental in addressing this crisis by producing compounded pediatric albuterol medications to meet the needs of children’s hospitals. As supply chain issues …
With February’s sudden shutdown of an Illinois manufacturing plant, STAQ’s production of Albuterol may be in even higher demand, according to a recent article by The Washington Post.
Albuterol — one of the most essential medications for pediatric patients — has been facing a critical shortage since June 2022. In partnership with Children’s Hospital Colorado (CHC), STAQ has been able to supply and maintain continuous albuterol for children’s hospitals. STAQ is committed to getting pediatric hospitals through this respiratory season and helping to …
Being able to make a positive impact on the critical Albuterol shortage is one of the reasons we got into this business. The “A” in STAQ stands for availability, after all.
The results of STAQ’s partnership with Angels for Change to address shortages of two critical medications for children are not going unnoticed. Watch CNN’s powerful story and/or read the article here.
As a direct result of STAQ’s partnership with Angels for Change, in just the first 6 months, more than 500,000 pediatric patients have had been protected from a shortage of Potassium Chloride (KCl) and 23.4% Sodium Chloride (NaCL). Read the full story.
As part of its partnership with Angels for Change, STAQ Pharma has been producing critically-needed medications for pediatric patients as part of a new program called projectPROTECT. Watch the full video (just under 7 minutes) now.
“STAQ Pharma is committed to supporting hospital pharmacies with their medication needs to care for their patients. We are honored to be chosen by Angels for Change and the Children’s Hospital Association to address this critical shortage situation,” said Mark Spiecker, president of STAQ Pharma. Read the full story.
In partnership with Children’s Hospital Colorado, STAQ has launched pre-filled, pediatric concentrations and doses of several important sterile compounded medications widely used in pediatric hospitals. Read the full article here.
